These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11136718)

  • 21. Synergistic interaction between histone deacetylase and topoisomerase II inhibitors is mediated through topoisomerase IIbeta.
    Marchion DC; Bicaku E; Turner JG; Daud AI; Sullivan DM; Munster PN
    Clin Cancer Res; 2005 Dec; 11(23):8467-75. PubMed ID: 16322310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The discovery and optimization of novel dual inhibitors of topoisomerase II and histone deacetylase.
    Zhang X; Bao B; Yu X; Tong L; Luo Y; Huang Q; Su M; Sheng L; Li J; Zhu H; Yang B; Zhang X; Chen Y; Lu W
    Bioorg Med Chem; 2013 Nov; 21(22):6981-95. PubMed ID: 24095018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Temporal and spatial distribution of DNA topoisomerase II alters during proliferation, differentiation, and apoptosis in HL-60 cells.
    Sugimoto K; Yamada K; Egashira M; Yazaki Y; Hirai H; Kikuchi A; Oshimi K
    Blood; 1998 Feb; 91(4):1407-17. PubMed ID: 9454772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selective inhibition of topoisomerase II by ICRF-193 does not support a role for topoisomerase II activity in the fragmentation of chromatin during apoptosis of human leukemia cells.
    Beere HM; Chresta CM; Hickman JA
    Mol Pharmacol; 1996 May; 49(5):842-51. PubMed ID: 8622634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear interactions of topoisomerase II alpha and beta with phospholipid scramblase 1.
    Wyles JP; Wu Z; Mirski SE; Cole SP
    Nucleic Acids Res; 2007; 35(12):4076-85. PubMed ID: 17567603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Topoisomerase II inhibitors fail to induce chromosome-type aberrations in etoposide-resistant cells: evidence for essential contribution of the cleavable complex formation to the induction of chromosome-type aberrations.
    Suzuki H; Tarumoto Y; Ohsawa M
    Mutagenesis; 1997 Jan; 12(1):29-33. PubMed ID: 9025094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tax relieves transcriptional repression by promoting histone deacetylase 1 release from the human T-cell leukemia virus type 1 long terminal repeat.
    Lu H; Pise-Masison CA; Linton R; Park HU; Schiltz RL; Sartorelli V; Brady JN
    J Virol; 2004 Jul; 78(13):6735-43. PubMed ID: 15194748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and biological evaluation of dual Topo II/HDAC inhibitors bearing pyrimido[5,4-b]indole and pyrazolo[3,4-d]pyrimidine motifs.
    Zhao M; Yang K; Zhu X; Gao T; Yu W; Liu H; You Z; Liu Z; Qiao X; Song Y
    Eur J Med Chem; 2023 Apr; 252():115303. PubMed ID: 36996717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metnase mediates chromosome decatenation in acute leukemia cells.
    Wray J; Williamson EA; Sheema S; Lee SH; Libby E; Willman CL; Nickoloff JA; Hromas R
    Blood; 2009 Aug; 114(9):1852-8. PubMed ID: 19458360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional interaction between human topoisomerase IIalpha and retinoblastoma protein.
    Bhat UG; Raychaudhuri P; Beck WT
    Proc Natl Acad Sci U S A; 1999 Jul; 96(14):7859-64. PubMed ID: 10393912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. WRN protects against topo I but not topo II inhibitors by preventing DNA break formation.
    Christmann M; Tomicic MT; Gestrich C; Roos WP; Bohr VA; Kaina B
    DNA Repair (Amst); 2008 Dec; 7(12):1999-2009. PubMed ID: 18805512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Casein kinase I delta/epsilon phosphorylates topoisomerase IIalpha at serine-1106 and modulates DNA cleavage activity.
    Grozav AG; Chikamori K; Kozuki T; Grabowski DR; Bukowski RM; Willard B; Kinter M; Andersen AH; Ganapathi R; Ganapathi MK
    Nucleic Acids Res; 2009 Feb; 37(2):382-92. PubMed ID: 19043076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Functional interaction of DNA topoisomerase IIalpha with the beta-catenin and T-cell factor-4 complex.
    Huang L; Shitashige M; Satow R; Honda K; Ono M; Yun J; Tomida A; Tsuruo T; Hirohashi S; Yamada T
    Gastroenterology; 2007 Nov; 133(5):1569-78. PubMed ID: 17983804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resistance to etoposide in human leukemia HL-60 cells: reduction in drug-induced DNA cleavage associated with hypophosphorylation of topoisomerase II phosphopeptides.
    Ganapathi R; Constantinou A; Kamath N; Dubyak G; Grabowski D; Krivacic K
    Mol Pharmacol; 1996 Aug; 50(2):243-8. PubMed ID: 8700130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changes in subcellular distribution of topoisomerase IIalpha correlate with etoposide resistance in multicell spheroids and xenograft tumors.
    Oloumi A; MacPhail SH; Johnston PJ; Banáth JP; Olive PL
    Cancer Res; 2000 Oct; 60(20):5747-53. PubMed ID: 11059769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cellular events involved in the sensitization of etoposide-resistant cells by inhibitors of calcium-calmodulin-dependent processes. Role for effects on apoptosis, DNA cleavable complex, and phosphorylation.
    Kawamura K; Grabowski D; Krivacic K; Hidaka H; Ganapathi R
    Biochem Pharmacol; 1996 Dec; 52(12):1903-9. PubMed ID: 8951349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA topoisomerases I and II in human mature sperm cells: characterization and unique properties.
    Har-Vardi I; Mali R; Breietman M; Sonin Y; Albotiano S; Levitas E; Potashnik G; Priel E
    Hum Reprod; 2007 Aug; 22(8):2183-9. PubMed ID: 17656417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity.
    Mo YY; Beck WT
    Exp Cell Res; 1999 Oct; 252(1):50-62. PubMed ID: 10502399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced etoposide sensitivity following adenovirus-mediated human topoisomerase IIalpha gene transfer is independent of topoisomerase IIbeta.
    Zhou Z; Zwelling LA; Ganapathi R; Kleinerman ES
    Br J Cancer; 2001 Sep; 85(5):747-51. PubMed ID: 11531262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA.
    Kim MS; Blake M; Baek JH; Kohlhagen G; Pommier Y; Carrier F
    Cancer Res; 2003 Nov; 63(21):7291-300. PubMed ID: 14612526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.